Search

Savara Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

5.29 -2.94

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

5.28

Max

5.49

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-2.9M

-40M

Pelnas, tenkantis vienai akcijai

-0.16

Darbuotojai

70

EBITDA

-3M

-40M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+111.32% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-10

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-54M

1.1B

Ankstesnė atidarymo kaina

8.23

Ankstesnė uždarymo kaina

5.29

Naujienos nuotaikos

By Acuity

50%

50%

119 / 339 reitingas Healthcare

Savara Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-22 20:05; UTC

Savara Inc's stock is declining sharply, moving from an initial gain to a notable drop, trading below its 20-day moving average.

2026-09-21 20:12; UTC

Savara Inc is advancing in after-market trading, positioned above its 20-day moving average and near the upper end of its one-month range.

2026-09-18 23:11; UTC

Savara Inc is trading modestly higher in after-market hours, reflecting the broader market's upward movement, with notable gains since Friday's close.

2026-09-17 23:11; UTC

Savara Inc is seeing a modest upward move in after-market trading, currently near the upper end of its one-month range.

2026-09-16 20:10; UTC

Savara Inc shares fell sharply today, continuing a decline since Tuesday and trading significantly below its 20-day moving average.

2026-09-15 20:07; UTC

Savara Inc shares are lower, impacted by a sharp decline in the NY Empire State Manufacturing Index and rising oil prices amid broader market weakness.

2026-09-11 20:08; UTC

Savara Inc. shares are trading lower today, continuing a decline since Thursday's close amid a broader market downturn.

2026-09-10 20:03; UTC

Savara Inc. shares are lower today, reflecting broader market conditions amid the European Central Bank's recent interest rate hike and inflation projections.

2026-09-04 19:26; UTC

Savara Inc shares are higher today, trading within a narrow range. The stock is currently near the lower end of its one-month range.

2026-09-03 20:02; UTC

Savara Inc shares are lower during Thursday's session, retracing from an earlier peak amid rising jobless claims that may affect Federal Reserve policy.

2026-09-02 20:08; UTC

Savara Inc. shares are higher today, driven by a significant upward trend in the Biotechnology sub-sector. No specific company news was identified.

2026-09-01 19:36; UTC

Savara Inc. shares are lower today, continuing a decline since Monday. The stock remains below its 20-day moving average amid rising inflation concerns.

2026-08-31 22:01; UTC

Savara Inc. shares rose in after-market trading, advancing since Monday's close, despite earlier pulling back from a session high. No specific news was identified.

2026-08-28 21:02; UTC

In after-market trading, Savara Inc. has increased following a flat start, indicating upward momentum despite remaining below its 20-day moving average.

2026-08-27 23:56; UTC

Savara Inc shares are higher in after-market trading, despite no specific news. Broader market sentiment remains mixed amid ongoing inflation concerns and upcoming Fed guidance.

2026-08-25 19:16; UTC

Event

Savara Inc announced presentations at the ERS Congress, yet shares are trading lower today, reflecting a slight decline since Monday's close.

2026-08-24 22:01; UTC

News

Savara Inc. will present Phase 3 trial results for molgramostim at the European Respiratory Society Congress in 2026. Shares are higher in after-market trading.

2026-08-21 19:36; UTC

News

Savara Inc. granted inducement awards to eight new employees, including options for 74,500 shares. Shares are higher since Thursday's close.

2026-08-20 20:02; UTC

Savara Inc shares are lower amid a broader market downturn, influenced by disappointing sales growth from major retailers like Walmart Inc. Trading volume remains unusually high.

2026-08-19 19:26; UTC

Savara Inc is trading higher today, maintaining upward momentum since Tuesday's close. The stock moved from a session low to a pre-market high.

2026-08-18 23:01; UTC

Savara Inc shares declined in after-market trading, falling below their 20-day moving average after an earlier surge. No specific news was identified to explain the volatility.

2026-08-17 19:46; UTC

Savara Inc is trading lower today, retracing from earlier gains and near the lower end of its one-month range. No specific news was identified.

2026-08-14 19:44; UTC

Savara Inc shares are higher today amid increased trading volume. No specific company news was identified to explain the price movement.

2026-08-13 20:02; UTC

Savara Inc shares are lower today, continuing a decline since Wednesday. The stock saw high trading volume amid no specific news.

2026-08-12 19:56; UTC

News

Savara Inc. shares are higher following Citizens' reaffirmation of its Outperform rating and $10 price target ahead of the MOLBREEVI PDUFA date.

2026-08-11 19:11; UTC

Savara Inc shares are lower today amid unusually high market volume. No specific news was identified to explain the decline.

2026-08-10 23:01; UTC

Savara Inc shares are lower in after-market trading, showing notable volatility without any specific news to explain the decline.

2026-08-07 19:36; UTC

Savara Inc is trading higher, benefiting from broader market gains following a weaker-than-expected jobs report that may delay Federal Reserve interest rate hikes.

2026-08-06 20:06; UTC

Savara Inc shares are higher today, recovering from earlier declines and trading above their 20-day moving average. No specific news was identified for the move.

2026-08-05 19:36; UTC

News

Savara Inc. shares are higher as the company advances its Biologics License Application for molgramostim, with a key PDUFA date approaching.

Akcijų palyginimas

Kainos pokytis

Savara Inc Prognozė

Kainos tikslas

By TipRanks

111.32% į viršų

12 mėnesių prognozė

Vidutinis 11.2 USD  111.32%

Aukščiausias 16 USD

Žemiausias 9 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Savara Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

5 ratings

5

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

119 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.